PMV Pharma stockholders re-elect Levine and Baum, approve say-on-pay and one-year frequency, ratify EY

PMV Pharmaceuticals, Inc.

Arnold Levine elected as Class II director with 29,469,991 FOR votes; Charles Baum with 29,134,747 FOR.
Non-binding say-on-pay approved: 32,962,908 FOR, 872,088 AGAINST.
Stockholders favored one-year frequency for future advisory votes on executive compensation (33,827,318 FOR one year).
Ernst & Young ratified as independent auditor for FY2022: 35,746,657 FOR, 4,223 AGAINST, 451 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.